Gabriel Ricolleau

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

Maxime P. Look, Wim L.J. van Putten, Michael J. Duffy et al. · JNCI Journal of the National Cancer Institute · 2002 · 604 citations · Full text

Medicine, Biostatistics, Oncology +15

bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer

Pascal Jézéquel, Mario Campone, Wilfried Gouraud et al. · Breast Cancer Research and Treatment · 2011 · 431 citations

Medicine, Bioinformatics, Oncology +14

bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses

P. Jezequel, Jean‐Sébastien Frenel, L. Campion et al. · Database · 2013 · 277 citations · Full text

Life Sciences, Bioinformatics, Molecular Biology +17

CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study

Jean‐Marc Riedinger, J Wafflart, Gabriel Ricolleau et al. · Annals of Oncology · 2006 · 104 citations · Full text

Medicine, Gynecology, Oncology +10

Validation of tumor‐associated macrophage ferritin light chain as a prognostic biomarker in node‐negative breast cancer tumors: A multicentric 2004 national PHRC study

Pascal Jézéquel, L. Campion, Frédérique Spyratos et al. · International Journal of Cancer · 2011 · 95 citations · Full text

Medicine, Oncology, Pathology +17